AbbVie 3Q Revenue Rises on Immunology and Neuroscience Strength
AbbVie raised its full-year profit outlook and quarterly dividend. The body ends before giving further details.
AbbVie raised its full-year profit outlook and quarterly dividend. The body ends before giving further details.